Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 7, 2015, Pages 251-256

  Keskin, Derin B ^a,b,c   Reinhold, Bruce B ^a,b,c   Zhang, Guang Lan ^b,c,d   Ivanov, Alexander R ^e   Karger, Barry L ^e   Reinherz, Ellis L ^a,b,c  

^a Department of Medical Oncology Laboratory of Immunobiology   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Boston University   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA A2 ANTIGEN; INFLUENZA VACCINE; STABLE ISOTOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; EXOCYTOSIS; HLA SYSTEM; HUMAN; HUMAN CELL; IC50; IMMUNE EVASION; IN VITRO STUDY; INFLUENZA A; INFLUENZA A (H3N2); INFLUENZA VIRUS A; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; LUNG ALVEOLUS EPITHELIUM; MASS SPECTROMETRY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS DETECTION; EPITHELIUM CELL; IMMUNOLOGY; INFLUENZA A VIRUS; LUNG; VIROLOGY;

INFLUENZA A VIRUS; MUS;

CD8-POSITIVE T-LYMPHOCYTES; CHROMATOGRAPHY, LIQUID; EPITHELIAL CELLS; EPITOPES; HUMANS; INFLUENZA A VIRUS; LUNG;

EID: 84923188707     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1423482112     Document Type: Article

References (33)

1. Dormitzer PR, et al. (2011) Influenza vaccine immunology. Immunol Rev 239(1): 167-177.
2. Drake JW (1993) Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci USA 90(9):4171-4175.
3. Heaton NS, Sachs D, Chen CJ, Hai R, Palese P (2013) Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc Natl Acad Sci USA 110(50):20248-20253.
4. Doherty PC, Turner SJ, Webby RG, Thomas PG (2006) Influenza and the challenge for immunology. Nat Immunol 7(5):449-455.
5. Krammer F, Palese P, Steel J (2015) Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr Top Microbiol Immunol 386:301-321.
6. Miller MS, Palese P (2014) Peering into the crystal ball: Influenza pandemics and vaccine efficacy. Cell 157(2):294-299.
7. Kumar P, Khanna M, Kumar B, Rajput R, Banerjea AC (2012) A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge. Antiviral Res 93(1):78-85.
8. Tan AC, et al. (2013) The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus. Immunol Cell Biol 91(1):96-104.
9. McMichael AJ, Gotch FM, Noble GR, Beare PA (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309(1):13-17.
10. Sridhar S, et al. (2013) Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 19(10):1305-1312.
11. Doherty PC, Kelso A (2008) Toward a broadly protective influenza vaccine. J Clin Invest 118(10):3273-3275.
12. Slütter B, Pewe LL, Kaech SM, Harty JT (2013) Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus. Immunity 39(5):939-948.
13. Wu T, et al. (2014) Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol 95(2):215-224.
14. Reinhold B, Keskin DB, Reinherz EL (2010) Molecular detection of targeted major histocompatibility complex I-bound peptides using a probabilistic measure and nanospray MS3 on a hybrid quadrupole-linear ion trap. Anal Chem 82(21):9090-9099.
15. Lundegaard C, Lund O, Nielsen M (2008) Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics 24(11):1397-1398.
16. Monroe M (2013) Normalized Elution Time (NET) Prediction Utility. Available at panomics.pnnl.gov. Accessed January 23, 2015.
17. Petritis K, et al. (2003) Use of artificial neural networks for the accurate prediction of peptide liquid chromatography elution times in proteome analyses. Anal Chem 75(5): 1039-1048.
18. Assarsson E, et al. (2008) Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 82(24):12241-12251.
19. Helft J, et al. (2012) Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J Clin Invest 122(11):4037-4047.
20. Tan AC, La Gruta NL, Zeng W, Jackson DC (2011) Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice. J Immunol 187(4):1895-1902.
21. Testa JS, et al. (2012) MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. PLoS ONE 7(11):e48484.
22. Wahl A, Schafer F, Bardet W, Hildebrand WH (2010) HLA class I molecules reflect an altered host proteome after influenza virus infection. Hum Immunol 71(1):14-22.
23. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A (2000) Human memory CTL response specific for influenza A virus is broad and multispecific. Hum Immunol 61(5): 438-452.
24. Zhang GL, et al. (2011) MULTIPRED2: A computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J Immunol Methods 374(1-2):53-61.
25. Ishizuka J, et al. (2008) The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 28(2):171-182.
26. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN (1996) Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4(6):565-571.
27. Kroeker AL, Ezzati P, Coombs KM, Halayko AJ (2013) Influenza A infection of primary human airway epithelial cells up-regulates proteins related to purine metabolism and ubiquitin-related signaling. J Proteome Res 12(7):3139-3151.
28. Antón LC, Yewdell JW (2014) Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors. J Leukoc Biol 95(4):551-562.
29. Ferguson AL, et al. (2013) Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity 38(3): 606-617.
30. Goulder PJ, Watkins DI (2004) HIV and SIV CTL escape: Implications for vaccine design. Nat Rev Immunol 4(8):630-640.
31. Berkhoff EG, et al. (2005) Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. J Virol 79(17):11239-11246.
32. Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ (2011) Viral evasion of T cell immunity: Ancient mechanisms offering new applications. Curr Opin Immunol 23(1): 96-103.
33. Schmolke M, García-Sastre A (2010) Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol 12(7):873-880.